Adenosine diphosphate-induced platelet activation inhibited by magnesium in a dosedependent manner

Obstetrics and Gynecology

Volumn 91, Issue 3, 1998, Pages 421-425

  Lynn Leaphart, W ^a,b   Meyer, Marjorie C ^a   Capeless, Eleanor L ^a   Tracy, Paula B ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b Central Georgia Hematology and Oncology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTIBODY; CD63 ANTIGEN; MAGNESIUM SULFATE; PADGEM PROTEIN; THROMBOCYTE ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PREECLAMPSIA; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

ADENOSINE DIPHOSPHATE; ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MAGNESIUM; P-SELECTIN; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; PREGNANCY;

EID: 0032030580     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00706-0     Document Type: Article

References (28)

1. 1. Pritchard JA, Pritchard SA. Standardized treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol 1975;123:543-52.
2. 2. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:201-5.
3. 3. Belfort MA, Moise KJ. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: A randomized, placebo-controlled study. Am J Obstet Gynecol 1992;167:661-6.
4. 4. Belfort MA, Saade GR, Moise KJ. The effect of magnesium sulfate on maternal retinal blood flow in preeclampsia: A randomized placebo-controlled study. Am J Obstet Gynecol 1992;167:1548-53.
5. 5. Becker RC, Tracy RP, Bovill EG, Mann KG, Ault K, for the TIMI-III Thrombosis and Anticoagulation Study Group. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. Coron Artery Dis 1994;5:339-45.
6. 6. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986;315:983-9.
7. 7. Hamm CW, Lorenz RL, Bleifeld W, Kupper W, Wober W, Weber PC. Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol 1987;10:998-1006.
8. 8. Fuster V, Chesebro JH. Antithrombotic therapy: Role of platelet inhibitor drugs. I. Thrombogenesis: Role of platelets. Mayo Clin Proc 1981;56:102-12.
9. 9. Janes SL, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in preeclampsia and pregnancy. Clin Sci 1994;86:731-9.
10. 10. Morrison R, Crawford J, MacPherson M, Heptinstall S. Platelet behavior in normal pregnancy, pregnancy complicated by essential hypertension, and pregnancy induced hypertension. Thromb Haemostas 1985;54:607-11.
11. 11. Sullivan MHF, Johnson S, Elder MG. Platelet malfunction preceding the onset of pregnancy induced hypertension. J Obstet Gynaecol 1990;10:215-6.
12. 12. Ballegeer VC, Spitz B, DeBaene LA, VanAssche AF, Hidajat M, Criel AM. Platelet activation and vascular damage in gestational hypertension. Am J Obstet Gynecol 1992;166:629-33.
13. 13. Gujrati VR, Goyal A, Guar SPS, Singh N, Shanker K, Chandravati. Relevance of platelet serotonergic mechanisms in pregnancy induced hypertension. Life Sci 1994;55:327-35.
14. 14. Rink TJ. Cytosolic calcium in platelet activation. Experentia 1988; 44:97-100.
15. 15. American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. ACOG technical bulletin no. 219. Washington DC: American College of Obstetricians and Gynecologists, 1996.
16. 16. Ault KA, Mitchell J. Analysis of platelets by flow cytometry. In: Darzynkiewicz Z, Robinson JP, Crissman HA, eds. Volume 42: Methods in cell biology. San Diego: Academic Press, 1994:275-94.
17. 17. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987;70:307-15.
18. 18. Abrams CS, Ellison N, Brudzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990;75:128-38.
19. 19. Grant BW, Nichols WL, Solberg LA, Yachimiak DJ, Mann KG. Quantitation of human in vitro megakaryocytopoesis by radioimmunoassay. Blood 1987;69:1334-9.
20. 20. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest 1986;78:130-7.
21. 21. Nieuwemhuis AK, Van Oosterhout JJG, Rozenmuller E, Van Iwaarden F, Sixma JJ. Studies with a monoclonal antibody against activated platelets: Evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987;70:838-45.
22. 22. Lewis JK, Hinshaw DB, Will AD, Hasso AN, Thompson JR. CT and angiographic correlation of severe neurological disease in toxaemia of pregnancy. Neuroradiology 1988;30:59-64.
23. 23. Musci TJ, Roberts JM, Rodgers GM, Taylor RN. Mitogenic activity is increased in sera of preeclamptic women before delivery. Am J Obstet Gynecol 1988;159:1446-51.
24. 24. Holmsen H, Kaplan KL, Dangelmaier CA. Differential energy requirements for platelet responses. Biochem J 1982;208:9-18.
25. 25. Verhoeven AJM, Mommersteeg ME, Akkerman JWN. Quantification of energy consumption in platelets during the thrombin-induced aggregation and secretion. Biochem J 1984;221:777-87.
26. 26. Watson KV, Moldow CF, Ogburn PL, Jacob HS. Magnesium sulfate: Rationale tor its use in preeclampsia. Proc Natl Acad Sci 1986:83:1075-8.
27. 27. Ravn HB, Vissinger H, Kristensen SD, Husted SE. Magnesium inhibits platelet activity - An in vitro study. Thromb Haemostas 1996;76:88-93.
28. 28. Ravn HB, Vissinger H, Kristensen SD, Wennmalm A, Thygesen K, Husted SE. Magnesium inhibits platelet activity - An infusion study in healthy volunteers. Thromb Haemostas 1996;75:939-44.